These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6150722)

  • 1. Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat.
    Hellenbrecht D; Enenkel J
    Arzneimittelforschung; 1984; 34(9):980-3. PubMed ID: 6150722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the intrinsic sympathomimetic activity of beta-adrenoceptor antagonists on haemodynamic effects in anaesthetized dogs.
    Wale JL; Austin M; Conway J; Reeves M
    Clin Exp Pharmacol Physiol; 1979; 6(1):11-9. PubMed ID: 32981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines.
    Bilski A; Robertson HH; Wale JL
    Clin Exp Pharmacol Physiol; 1979; 6(1):1-9. PubMed ID: 32980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity studies of beta-adrenoceptor blocking drugs to decrease ventricular arrhythmias in guinea pigs.
    Gortner L; Hellenbrecht D
    Arzneimittelforschung; 1988 Dec; 38(12):1796-9. PubMed ID: 2907727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic sympathomimetic activity and coronary blood flow.
    Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1982; 13(Suppl 2):175S-180S. PubMed ID: 6125167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
    Harry JD; Knapp MF; Linden RJ; Stoker JB; Newcombe C
    Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenoceptor blockade and atrio-ventricular conduction in dogs. Role of intrinsic sympathomimetic activity.
    Giudicelli JF; Lhoste F
    Br J Clin Pharmacol; 1982; 13(Suppl 2):167S-174S. PubMed ID: 6125166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs.
    Bilski A; Wale J; Dawes PM
    Br J Pharmacol; 1976 Mar; 56(3):362P. PubMed ID: 4182
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypotensive responses following oral adminstration of beta-adrenoceptor blocking drugs to the conscious cat.
    Burden DT; Hamilton TC
    Eur J Pharmacol; 1976 Jul; 38(1):55-61. PubMed ID: 8319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM
    J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonspecific membrane effects of CH-103: hydrophobicity, surface activity and membrane fluidity studies in comparison with propranolol and practolol.
    Varga E; Szöllösi J; Antal K; Kovács P; Szabó JZ
    Pharmazie; 1999 May; 54(5):380-4. PubMed ID: 10368833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between hydrophobicity and non-specific pharmacological effects of beta-adrenoceptor blocking agents.
    Hellenbrecht D; Gortner L
    Pol J Pharmacol Pharm; 1976; 28(6):625-30. PubMed ID: 13353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Suicidal attempts with beta-adrenoceptor blocking agents.
    Boakes AJ; Boeree BH
    Br Med J; 1973 Dec; 4(5893):675. PubMed ID: 4148463
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
    Zechel HJ
    Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of beta-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anaesthetized rats.
    Campbell CA; Parratt JR
    Br J Pharmacol; 1983 Aug; 79(4):939-46. PubMed ID: 6140049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.